| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | steroid 21-monooxygenase activity | 1.31e-05 | 4 | 30 | 2 | GO:0004509 | |
| GeneOntologyMolecularFunction | anandamide 8,9 epoxidase activity | 1.31e-05 | 4 | 30 | 2 | GO:0062187 | |
| GeneOntologyMolecularFunction | anandamide 11,12 epoxidase activity | 1.31e-05 | 4 | 30 | 2 | GO:0062188 | |
| GeneOntologyMolecularFunction | progesterone 21-hydroxylase activity | 1.31e-05 | 4 | 30 | 2 | GO:0106309 | |
| GeneOntologyMolecularFunction | anandamide 14,15 epoxidase activity | 3.26e-05 | 6 | 30 | 2 | GO:0062189 | |
| GeneOntologyMolecularFunction | anandamide epoxidase activity | 3.26e-05 | 6 | 30 | 2 | GO:0062186 | |
| GeneOntologyMolecularFunction | arachidonate monooxygenase activity | 7.48e-04 | 27 | 30 | 2 | GO:0008391 | |
| GeneOntologyMolecularFunction | steroid hydroxylase activity | 1.19e-03 | 34 | 30 | 2 | GO:0008395 | |
| GeneOntologyMolecularFunction | aromatase activity | 1.26e-03 | 35 | 30 | 2 | GO:0070330 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen | 1.64e-03 | 40 | 30 | 2 | GO:0016709 | |
| GeneOntologyMolecularFunction | iron ion binding | 1.94e-03 | 166 | 30 | 3 | GO:0005506 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen | 2.46e-03 | 49 | 30 | 2 | GO:0016712 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen | 3.02e-03 | 194 | 30 | 3 | GO:0016705 | |
| GeneOntologyMolecularFunction | coreceptor activity | 5.22e-03 | 72 | 30 | 2 | GO:0015026 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 7.34e-03 | 1180 | 30 | 6 | GO:0022857 | |
| GeneOntologyBiologicalProcess | serotonin biosynthetic process from tryptophan | 6.13e-06 | 3 | 30 | 2 | GO:0006587 | |
| GeneOntologyBiologicalProcess | serotonin biosynthetic process | 5.70e-05 | 8 | 30 | 2 | GO:0042427 | |
| GeneOntologyBiologicalProcess | indole-containing compound biosynthetic process | 9.14e-05 | 10 | 30 | 2 | GO:0042435 | |
| GeneOntologyBiologicalProcess | primary amino compound biosynthetic process | 9.14e-05 | 10 | 30 | 2 | GO:1901162 | |
| GeneOntologyBiologicalProcess | oxidative demethylation | 1.34e-04 | 12 | 30 | 2 | GO:0070989 | |
| GeneOntologyBiologicalProcess | tryptophan metabolic process | 1.84e-04 | 14 | 30 | 2 | GO:0006568 | |
| GeneOntologyBiologicalProcess | indolalkylamine metabolic process | 2.42e-04 | 16 | 30 | 2 | GO:0006586 | |
| GeneOntologyBiologicalProcess | dopamine biosynthetic process | 2.74e-04 | 17 | 30 | 2 | GO:0042416 | |
| GeneOntologyBiologicalProcess | serotonin metabolic process | 3.08e-04 | 18 | 30 | 2 | GO:0042428 | |
| GeneOntologyBiologicalProcess | dolichol-linked oligosaccharide biosynthetic process | 4.64e-04 | 22 | 30 | 2 | GO:0006488 | |
| GeneOntologyBiologicalProcess | primary amino compound metabolic process | 5.08e-04 | 23 | 30 | 2 | GO:1901160 | |
| GeneOntologyBiologicalProcess | demethylation | 5.53e-04 | 24 | 30 | 2 | GO:0070988 | |
| GeneOntologyBiologicalProcess | dolichol metabolic process | 5.53e-04 | 24 | 30 | 2 | GO:0019348 | |
| GeneOntologyBiologicalProcess | catecholamine biosynthetic process | 8.10e-04 | 29 | 30 | 2 | GO:0042423 | |
| GeneOntologyBiologicalProcess | catechol-containing compound biosynthetic process | 8.10e-04 | 29 | 30 | 2 | GO:0009713 | |
| GeneOntologyBiologicalProcess | polyprenol metabolic process | 8.10e-04 | 29 | 30 | 2 | GO:0016093 | |
| GeneOntologyBiologicalProcess | indole-containing compound metabolic process | 9.26e-04 | 31 | 30 | 2 | GO:0042430 | |
| GeneOntologyBiologicalProcess | ammonium ion metabolic process | 9.87e-04 | 32 | 30 | 2 | GO:0097164 | |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 1.18e-03 | 144 | 30 | 3 | GO:0006720 | |
| GeneOntologyBiologicalProcess | xenobiotic catabolic process | 1.32e-03 | 37 | 30 | 2 | GO:0042178 | |
| GeneOntologyBiologicalProcess | C21-steroid hormone metabolic process | 1.95e-03 | 45 | 30 | 2 | GO:0008207 | |
| GeneOntologyBiologicalProcess | aromatic amino acid metabolic process | 2.03e-03 | 46 | 30 | 2 | GO:0009072 | |
| GeneOntologyBiologicalProcess | biogenic amine biosynthetic process | 2.12e-03 | 47 | 30 | 2 | GO:0042401 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound metabolic process | 2.13e-03 | 641 | 30 | 5 | GO:1901615 | |
| GeneOntologyBiologicalProcess | amine biosynthetic process | 2.21e-03 | 48 | 30 | 2 | GO:0009309 | |
| GeneOntologyBiologicalProcess | dopamine metabolic process | 2.69e-03 | 53 | 30 | 2 | GO:0042417 | |
| GeneOntologyBiologicalProcess | alcohol metabolic process | 2.85e-03 | 412 | 30 | 4 | GO:0006066 | |
| GeneOntologyBiologicalProcess | phenol-containing compound biosynthetic process | 3.11e-03 | 57 | 30 | 2 | GO:0046189 | |
| GeneOntologyCellularComponent | endoplasmic reticulum membrane | DISP3 CYP2D6 ORMDL2 TMEM94 PIEZO1 SLC35D3 ALG10 DOLK CNIH1 RETREG1 | 7.60e-06 | 1293 | 30 | 10 | GO:0005789 |
| GeneOntologyCellularComponent | endoplasmic reticulum subcompartment | DISP3 CYP2D6 ORMDL2 TMEM94 PIEZO1 SLC35D3 ALG10 DOLK CNIH1 RETREG1 | 7.91e-06 | 1299 | 30 | 10 | GO:0098827 |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | DISP3 CYP2D6 ORMDL2 TMEM94 PIEZO1 SLC35D3 ALG10 DOLK CNIH1 RETREG1 | 9.56e-06 | 1327 | 30 | 10 | GO:0042175 |
| HumanPheno | Pulmonary venous hypertension | 7.73e-05 | 9 | 8 | 2 | HP:0030950 | |
| HumanPheno | Interstitial cardiac fibrosis | 9.65e-05 | 10 | 8 | 2 | HP:0031329 | |
| MousePheno | abnormal limb bud morphology | 1.35e-05 | 91 | 23 | 4 | MP:0005650 | |
| MousePheno | abnormal limb development | 7.36e-05 | 140 | 23 | 4 | MP:0006279 | |
| MousePheno | decreased urine calcium level | 1.16e-04 | 10 | 23 | 2 | MP:0002986 | |
| MousePheno | abnormal urine osmolality | 1.59e-04 | 65 | 23 | 3 | MP:0002987 | |
| MousePheno | abnormal cardiovascular development | 2.17e-04 | 802 | 23 | 7 | MP:0002925 | |
| MousePheno | abnormal prenatal body size | 2.66e-04 | 1116 | 23 | 8 | MP:0010866 | |
| MousePheno | abnormal skin morphology | 2.94e-04 | 1455 | 23 | 9 | MP:0002060 | |
| Domain | - | 1.64e-02 | 663 | 28 | 4 | 2.60.40.10 | |
| Domain | GPCR_Rhodpsn_7TM | 1.69e-02 | 670 | 28 | 4 | IPR017452 | |
| Domain | 7tm_1 | 1.75e-02 | 677 | 28 | 4 | PF00001 | |
| Domain | G_PROTEIN_RECEP_F1_1 | 1.82e-02 | 685 | 28 | 4 | PS00237 | |
| Domain | G_PROTEIN_RECEP_F1_2 | 1.88e-02 | 691 | 28 | 4 | PS50262 | |
| Domain | GPCR_Rhodpsn | 1.89e-02 | 692 | 28 | 4 | IPR000276 | |
| Domain | Ig-like_fold | 2.01e-02 | 706 | 28 | 4 | IPR013783 | |
| Domain | Ig_sub | 2.45e-02 | 421 | 28 | 3 | IPR003599 | |
| Domain | IG | 2.45e-02 | 421 | 28 | 3 | SM00409 | |
| Pathway | REACTOME_CYP2E1_REACTIONS | 1.38e-04 | 12 | 21 | 2 | MM14847 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_MARESINS | 1.38e-04 | 12 | 21 | 2 | MM15616 | |
| Pathway | REACTOME_MISCELLANEOUS_SUBSTRATES | 3.19e-04 | 18 | 21 | 2 | MM14843 | |
| Pathway | REACTOME_FATTY_ACIDS | 3.19e-04 | 18 | 21 | 2 | MM14841 | |
| Pathway | REACTOME_BIOSYNTHESIS_OF_SPECIALIZED_PRORESOLVING_MEDIATORS_SPMS | 4.80e-04 | 22 | 21 | 2 | MM15614 | |
| Pathway | REACTOME_XENOBIOTICS | 6.21e-04 | 25 | 21 | 2 | MM14846 | |
| Pathway | REACTOME_ASPIRIN_ADME | 2.01e-03 | 45 | 21 | 2 | MM15694 | |
| Pubmed | Characterization of Cyp2d22, a novel cytochrome P450 expressed in mouse mammary cells. | 7.19e-07 | 2 | 30 | 2 | 11032406 | |
| Pubmed | Characterization of the common genetic defect in humans deficient in debrisoquine metabolism. | 7.19e-07 | 2 | 30 | 2 | 3123997 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 19594327 | ||
| Pubmed | Coding-noncoding gene expression in intrahepatic cholangiocarcinoma. | 7.19e-07 | 2 | 30 | 2 | 26297049 | |
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 25808902 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 11207030 | ||
| Pubmed | 7.19e-07 | 2 | 30 | 2 | 15051713 | ||
| Pubmed | 2.16e-06 | 3 | 30 | 2 | 2574001 | ||
| Pubmed | Identification of the primary gene defect at the cytochrome P450 CYP2D locus. | 2.16e-06 | 3 | 30 | 2 | 1978251 | |
| Pubmed | Polymorphism of metabolic genes and susceptibility to occupational chronic manganism. | 1.08e-05 | 6 | 30 | 2 | 12171760 | |
| Pubmed | Effects of infection of MRSA on the expression and activity of renal cytochrome P450s in mice. | 1.51e-05 | 7 | 30 | 2 | 30944282 | |
| Pubmed | 2.31e-04 | 26 | 30 | 2 | 23181366 | ||
| Pubmed | 2.99e-04 | 151 | 30 | 3 | 18457437 | ||
| Pubmed | E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins. | 3.85e-04 | 736 | 30 | 5 | 29676528 | |
| Pubmed | A mouse knockout library for secreted and transmembrane proteins. | 6.30e-04 | 460 | 30 | 4 | 20562862 | |
| Pubmed | Comparative expression profiling of 40 mouse cytochrome P450 genes in embryonic and adult tissues. | 6.65e-04 | 44 | 30 | 2 | 12745259 | |
| Pubmed | 8.25e-04 | 214 | 30 | 3 | 22199357 | ||
| Interaction | ENPP3 interactions | 6.19e-05 | 9 | 27 | 2 | int:ENPP3 | |
| Interaction | CRELD1 interactions | 6.26e-05 | 163 | 27 | 4 | int:CRELD1 | |
| Cytoband | 17q25.1 | 1.30e-03 | 81 | 30 | 2 | 17q25.1 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr16q24 | 3.59e-03 | 136 | 30 | 2 | chr16q24 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr9p13 | 5.79e-03 | 174 | 30 | 2 | chr9p13 | |
| GeneFamily | Solute carriers | 4.26e-04 | 395 | 17 | 4 | 752 | |
| GeneFamily | Cytochrome P450 family 2 | 4.86e-04 | 35 | 17 | 2 | 1001 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.83e-05 | 129 | 30 | 3 | e7a15f98c3e6e4ee317e21958be3e413e3acd101 | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Renal_corpuscle_epithelial_cell|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-04 | 155 | 30 | 3 | 90e629681a72baacc7981b82883866a487638dbc | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.52e-04 | 155 | 30 | 3 | 7aba8ef53c9170ad8ed955c904c8991097ab1e32 | |
| ToppCell | Control-B_naive-1|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 1.52e-04 | 155 | 30 | 3 | 0a78d1cab2bdba2dc8a74cdf35b5a0192370c4b5 | |
| ToppCell | droplet-Marrow-BM-30m-Lymphocytic-NK_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.80e-04 | 164 | 30 | 3 | b77995958c938e10a526118f75d78cee72e0b207 | |
| ToppCell | 3'_v3-Lung-Lymphocytic_B-ABC_aged-B_memory|Lung / Manually curated celltypes from each tissue | 1.80e-04 | 164 | 30 | 3 | 7766900740f67dbbe3c4d90fbfdcc1665cee6515 | |
| ToppCell | Control-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 1.86e-04 | 166 | 30 | 3 | 32ebaefa6c074b28193fff764ee7c2c0e9357e20 | |
| ToppCell | Control-Epithelial-Mesothelial|Control / Disease state, Lineage and Cell class | 1.86e-04 | 166 | 30 | 3 | 1ed3788257e14f097862b999f020bfe2a57de52b | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_1-Mesothelial|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.25e-04 | 177 | 30 | 3 | 0912a291cff32a4ff8a2d7680ed1a1cd867fb90f | |
| ToppCell | 5'-Adult-LymphNode-Endothelial-lymphatic_endothelial-LEC5_(CLDN11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.29e-04 | 178 | 30 | 3 | 4b3ea0921bc598ebb9f63780ecdf8ad4349f3666 | |
| ToppCell | ASK440-Epithelial-Transformed_epithelium|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.29e-04 | 178 | 30 | 3 | 86f1741636ed3e85bb4a65f84949b718fc38c290 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 2.32e-04 | 179 | 30 | 3 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0.5|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 2.44e-04 | 182 | 30 | 3 | c98da2db197b1531204e116600ff51891e5c17af | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Renal_corpuscle_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.56e-04 | 185 | 30 | 3 | b848b63aff4d9dbb9e66a85876d4c7c6dacd0579 | |
| ToppCell | COPD-Epithelial-Mesothelial|World / Disease state, Lineage and Cell class | 2.56e-04 | 185 | 30 | 3 | 23579988036fc1925992c31919750f9b3fe9f790 | |
| ToppCell | facs-GAT-Fat-24m-Endothelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-04 | 190 | 30 | 3 | da2fcd4a2cc6e45c8174109d892f1424e39919a1 | |
| ToppCell | facs-GAT-Fat-24m-Endothelial-endothelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-04 | 190 | 30 | 3 | e584eaccbc22aa7f7a4340ed8a2a8b45ddca93f4 | |
| ToppCell | facs-Heart-RV-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-04 | 190 | 30 | 3 | 89d1d686cc683206534e2157554d7d0df5d53497 | |
| ToppCell | facs-GAT-Fat-24m-Endothelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-04 | 190 | 30 | 3 | 3395b2ff6ffadf84cdb1b5a37a5b6be05b56c30f | |
| ToppCell | facs-Pancreas-Exocrine-3m-Endothelial|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-04 | 190 | 30 | 3 | b7fc451e160e31dc898b122de844b501f587db67 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Endothelial-endothelial_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-04 | 190 | 30 | 3 | 83cc851fb9f644b17a8ebf4d99a646003769a22f | |
| ToppCell | facs-Pancreas-Exocrine-3m-Endothelial-nan|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-04 | 190 | 30 | 3 | 5f440d4b334d66d419c03bd828f7d93f16c1ce67 | |
| ToppCell | facs-Heart-RV-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.77e-04 | 190 | 30 | 3 | 65ba6c4f4a2905c0bf4ff99518ae49e3dfd5e640 | |
| ToppCell | facs-SCAT-Fat-3m-Endothelial-nan|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-04 | 191 | 30 | 3 | a0018f88f7132477cc467ee15db029a585290595 | |
| ToppCell | facs-Heart-LA-3m-Endothelial-coronary_vascular_endothelial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-04 | 191 | 30 | 3 | 827be47d3574c6c5b021c6f1c1670834344f10cb | |
| ToppCell | facs-SCAT-Fat-3m-Endothelial-endothelial_cell|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-04 | 191 | 30 | 3 | 6b9bbf4a63d4e9a8075bb06c2aa644fcf4ee88b8 | |
| ToppCell | facs-Heart-LA-3m-Endothelial-endothelial_cell_of_coronary_artery|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-04 | 191 | 30 | 3 | a15f0fb4bd7dd77ef5f931b6fc9d68697deec1d1 | |
| ToppCell | 10x5'v1-week_17-19-Endothelial-stroma-proliferating_EC|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.81e-04 | 191 | 30 | 3 | dc9e5eb6aa31b8d79aeec33e59b9138dfb469a3b | |
| ToppCell | facs-SCAT-Fat-3m-Endothelial|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-04 | 191 | 30 | 3 | 90f0c193dce267a4f1a9b2501f636dafd0a34cf7 | |
| ToppCell | 11.5-Airway-Epithelial-Neuroendocrine|Airway / Age, Tissue, Lineage and Cell class | 2.81e-04 | 191 | 30 | 3 | c1bb3ae5c297f55cdadf5b6e53d5296389d5099e | |
| ToppCell | facs-Heart-RV-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.81e-04 | 191 | 30 | 3 | 84ebb9f8e975acc88aa600c08a8aa791256948a6 | |
| ToppCell | PCW_13-14-Epithelial-Epithelial_neuroendo-epi_neuroendocrine2[NE2]_(12)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.81e-04 | 191 | 30 | 3 | 19832ddd559a353e1618fe853d79e3edfec6dcda | |
| ToppCell | PCW_10-12-Epithelial-Epithelial_neuroendo-epi_neuroendocrine2[NE2]_(12)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.85e-04 | 192 | 30 | 3 | 4d3a1c267739b1479217144656986972fc86db43 | |
| ToppCell | wk_08-11-Mesenchymal-Mesothelial-intermediate_mesothelial|wk_08-11 / Celltypes from embryonic and fetal-stage human lung | 2.85e-04 | 192 | 30 | 3 | ac9e5288ecd4b1e142f2e15a1fcd11c8eb9e15cd | |
| ToppCell | facs-Heart-RA-3m-Endothelial|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.99e-04 | 195 | 30 | 3 | f4fdcc0b851392086e9618e76ee6a0b540d5fb3c | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.99e-04 | 195 | 30 | 3 | 3b79e6bb525b17192ecec9e1227a29c419968144 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-E-|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.99e-04 | 195 | 30 | 3 | 65fc50e3818e902028fc4226070fa57609c66b9c | |
| ToppCell | Mesenchymal_cells-Fibro/Chondro_p.|Mesenchymal_cells / Lineage and Cell class | 2.99e-04 | 195 | 30 | 3 | b95a631d54c6cf85e48e1e638703206aaaebc073 | |
| ToppCell | Endothelial|World / shred by cell class for bronchial biopsy | 2.99e-04 | 195 | 30 | 3 | f0e46e859f7a9bdead3203889f7e20fa21f76ff0 | |
| ToppCell | facs-GAT-Fat-3m-Endothelial|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-04 | 196 | 30 | 3 | b6cc1f466d45479764080d34b1daeb8243a5a9f3 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.03e-04 | 196 | 30 | 3 | ee45e4de9d706ec87094e87f47d3e514539b8092 | |
| ToppCell | facs-GAT-Fat-3m-Endothelial-endothelial_cell|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-04 | 196 | 30 | 3 | ede6104cdfa4ee5287efcca9bbc36677cbf7a8d8 | |
| ToppCell | facs-GAT-Fat-3m-Endothelial-nan|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.03e-04 | 196 | 30 | 3 | 039044ab28c53391c34d8226fb8cf78549e63ef4 | |
| ToppCell | 10x3'2.3-week_14-16-Mesenchymal_fibro-stroma|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 3.03e-04 | 196 | 30 | 3 | fa4a85a3cd52df0da5dfedc0e584e9df8c61ce89 | |
| ToppCell | tumor_Lung-Endothelial_cells|tumor_Lung / Location, Cell class and cell subclass | 3.08e-04 | 197 | 30 | 3 | 6870b311c54a73723768276a58456620f5217d43 | |
| ToppCell | (6)_Endothelial-A_(Artery)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 3.12e-04 | 198 | 30 | 3 | 44f8cd5afa3685dcc8bfea0b15af5e8817e12e2e | |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Mesothelial_cells|Biopsy_Other_PF / Sample group, Lineage and Cell type | 3.12e-04 | 198 | 30 | 3 | 86736f01e61bf4961f060b24ee1f1f48340737dd | |
| ToppCell | tumor_Lung-Endothelial_cells-Tumor_ECs|tumor_Lung / Location, Cell class and cell subclass | 3.12e-04 | 198 | 30 | 3 | 5228c4bf2513186140c2c4eaa67a268c732bdc84 | |
| ToppCell | (2)_Fibroblasts-(23)_Fibro-4|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 3.12e-04 | 198 | 30 | 3 | e0ef49ec0f87cc87b45efa297b9ff6c35b7a2ba9 | |
| ToppCell | metastatic_Brain-Endothelial_cells-Tumor_ECs|metastatic_Brain / Location, Cell class and cell subclass | 3.12e-04 | 198 | 30 | 3 | 5e274f29cc796dae7d64d6035e904816c25f9914 | |
| ToppCell | metastatic_Brain-Endothelial_cells|metastatic_Brain / Location, Cell class and cell subclass | 3.12e-04 | 198 | 30 | 3 | 97ef7946ef11ac93318c1dd46b548dc01e5a6aba | |
| ToppCell | 367C-Endothelial_cells|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.17e-04 | 199 | 30 | 3 | 636ff80938907f137e955388797072ab45289062 | |
| Drug | 3-methoxyphenethylamine | 1.68e-06 | 2 | 30 | 2 | CID000074866 | |
| Drug | cupreidine | 1.68e-06 | 2 | 30 | 2 | CID000051196 | |
| Drug | chlorpromazine N-oxide | 5.03e-06 | 3 | 30 | 2 | CID000443037 | |
| Drug | 2,4,6-trimethylbenzaldoxime | 5.03e-06 | 3 | 30 | 2 | CID000283782 | |
| Drug | O-demethyl encainide | 5.03e-06 | 3 | 30 | 2 | CID000054736 | |
| Drug | 1-(1-phenylcyclohexyl)-4-piperidinol | 1.01e-05 | 4 | 30 | 2 | CID000098840 | |
| Drug | 4,4'-difluorobenzophenone | 1.01e-05 | 4 | 30 | 2 | CID000009582 | |
| Drug | desethylaprindine | 1.01e-05 | 4 | 30 | 2 | CID000162697 | |
| Drug | Z-10 | 1.01e-05 | 4 | 30 | 2 | CID000477529 | |
| Drug | bisoprolol | 1.56e-05 | 37 | 30 | 3 | CID000002405 | |
| Drug | eptapirone | 1.67e-05 | 5 | 30 | 2 | CID000208928 | |
| Drug | 2Cmp | 1.67e-05 | 5 | 30 | 2 | CID000023392 | |
| Drug | Koe 1801 | 1.67e-05 | 5 | 30 | 2 | CID000129632 | |
| Drug | L-754,394 | 1.67e-05 | 5 | 30 | 2 | CID005481990 | |
| Drug | oxosparteine | 1.67e-05 | 5 | 30 | 2 | CID000097492 | |
| Drug | threohydrobupropion | 1.67e-05 | 5 | 30 | 2 | CID000000445 | |
| Drug | 4-hydroxyochratoxin A | 1.67e-05 | 5 | 30 | 2 | CID000114713 | |
| Drug | fenproporex | 1.67e-05 | 5 | 30 | 2 | CID000061810 | |
| Drug | 8-Methylxanthine | 2.51e-05 | 6 | 30 | 2 | CID000087061 | |
| Drug | AC1L45F6 | 2.51e-05 | 6 | 30 | 2 | CID000150982 | |
| Drug | nitroguanidine | 2.51e-05 | 6 | 30 | 2 | CID000011174 | |
| Drug | 10-hydroxyochratoxin A | 2.51e-05 | 6 | 30 | 2 | CID000135115 | |
| Drug | KRM1674 | 2.51e-05 | 6 | 30 | 2 | CID000126235 | |
| Drug | 5-dehydrosparteine | 2.51e-05 | 6 | 30 | 2 | CID000160614 | |
| Drug | 7-hydroxychlorpromazine | 2.51e-05 | 6 | 30 | 2 | CID000016414 | |
| Drug | AC1NV8O5 | 2.82e-05 | 45 | 30 | 3 | CID005473386 | |
| Drug | RI-331 | 3.22e-05 | 47 | 30 | 3 | CID000160754 | |
| Drug | quinidine-N-oxide | 3.51e-05 | 7 | 30 | 2 | CID000050979 | |
| Drug | Ben 101 | 3.51e-05 | 7 | 30 | 2 | CID000090766 | |
| Drug | 2-sulfamoylacetylphenol | 3.51e-05 | 7 | 30 | 2 | CID000194588 | |
| Drug | phenyl isocyanide | 3.51e-05 | 7 | 30 | 2 | CID000013606 | |
| Drug | azoprocarbazine | 3.51e-05 | 7 | 30 | 2 | CID000075230 | |
| Drug | ICI-199,441 | 3.51e-05 | 7 | 30 | 2 | CID003082717 | |
| Drug | 5,6-Dehydro-sparteine | 3.51e-05 | 7 | 30 | 2 | CID000523578 | |
| Drug | 2D7 | 3.65e-05 | 49 | 30 | 3 | CID005327103 | |
| Drug | hydroxynortriptyline | 4.68e-05 | 8 | 30 | 2 | CID005352542 | |
| Drug | MPBP | 4.68e-05 | 8 | 30 | 2 | CID000129775 | |
| Drug | pirprofen | 4.68e-05 | 8 | 30 | 2 | CID000035935 | |
| Drug | phenmetrazine | 4.68e-05 | 8 | 30 | 2 | CID000004762 | |
| Drug | L-754394 | 4.68e-05 | 8 | 30 | 2 | CID000153982 | |
| Drug | B.W.306U | 4.68e-05 | 8 | 30 | 2 | CID000000446 | |
| Drug | Z H-H | 4.68e-05 | 8 | 30 | 2 | CID000004657 | |
| Drug | AC1L9DBW | 4.68e-05 | 8 | 30 | 2 | CID000442742 | |
| Drug | 3,4-dihydroxymethamphetamine | 4.68e-05 | 8 | 30 | 2 | CID000161126 | |
| Drug | HCBz | 4.68e-05 | 8 | 30 | 2 | CID000196604 | |
| Drug | beta-site | 4.68e-05 | 8 | 30 | 2 | CID000003914 | |
| Drug | Methamphetamine | 5.42e-05 | 1401 | 30 | 9 | ctd:D008694 | |
| Drug | hydroquinidine hydrochloride | 6.01e-05 | 9 | 30 | 2 | CID000003649 | |
| Drug | p-hydroxymexiletine | 6.01e-05 | 9 | 30 | 2 | CID000093286 | |
| Drug | O-demethylmetoprolol | 6.01e-05 | 9 | 30 | 2 | CID000162181 | |
| Drug | guanoxan | 6.01e-05 | 9 | 30 | 2 | CID000016564 | |
| Drug | 1-chlorobutane | 6.01e-05 | 9 | 30 | 2 | CID000008005 | |
| Drug | CP-101,606 | 6.01e-05 | 9 | 30 | 2 | CID000219101 | |
| Drug | AC1O3M98 | 6.01e-05 | 9 | 30 | 2 | CID006332100 | |
| Drug | norethylmorphine | 6.01e-05 | 9 | 30 | 2 | CID005464196 | |
| Drug | norchlorpromazine | 7.50e-05 | 10 | 30 | 2 | CID000062875 | |
| Drug | AC1LCF1O | 7.50e-05 | 10 | 30 | 2 | CID000627285 | |
| Drug | AC1L1IDP | 7.50e-05 | 10 | 30 | 2 | CID000004535 | |
| Drug | benzaldehyde oxime | 7.50e-05 | 10 | 30 | 2 | CID000012143 | |
| Drug | 2-hydroxydesipramine | 7.50e-05 | 10 | 30 | 2 | CID000121249 | |
| Drug | 4-hydroxydebrisoquine | 7.50e-05 | 10 | 30 | 2 | CID000107669 | |
| Drug | 9-benzyladenine | 9.16e-05 | 11 | 30 | 2 | CID000020262 | |
| Drug | naphthohydroquinone | 9.16e-05 | 11 | 30 | 2 | CID000011305 | |
| Drug | 8-hydroxycarteolol | 9.16e-05 | 11 | 30 | 2 | CID000124688 | |
| Drug | vindoline | 9.16e-05 | 11 | 30 | 2 | CID000016596 | |
| Drug | 4-hydroxy-3-methoxymethamphetamine | 9.16e-05 | 11 | 30 | 2 | CID003081137 | |
| Drug | sphondin | 9.16e-05 | 11 | 30 | 2 | CID000108104 | |
| Drug | methoxyphenamine | 1.10e-04 | 12 | 30 | 2 | CID000004117 | |
| Drug | D02861 | 1.10e-04 | 12 | 30 | 2 | CID011954281 | |
| Drug | phenylacetone | 1.10e-04 | 12 | 30 | 2 | CID000007678 | |
| Drug | 16 alpha-hydroxytestosterone | 1.10e-04 | 12 | 30 | 2 | CID000065545 | |
| Drug | 2-Tbmbfd | 1.10e-04 | 12 | 30 | 2 | CID000126928 | |
| Drug | Doxycycline hydrochloride [10592-13-9]; Up 200; 8.4uM; MCF7; HT_HG-U133A | 1.11e-04 | 191 | 30 | 4 | 7195_UP | |
| Drug | chloral | 1.21e-04 | 73 | 30 | 3 | CID000006407 | |
| Drug | Glycopyrrolate [596-51-0]; Down 200; 10uM; PC3; HT_HG-U133A | 1.27e-04 | 198 | 30 | 4 | 3687_DN | |
| Drug | chlorpromazine hydrochloride; Down 200; 1uM; HL60; HT_HG-U133A | 1.27e-04 | 198 | 30 | 4 | 1158_DN | |
| Drug | AC1L1N5A | 1.30e-04 | 13 | 30 | 2 | CID000006717 | |
| Drug | Sordinol | 1.30e-04 | 13 | 30 | 2 | CID000012453 | |
| Drug | bergaptol | 1.30e-04 | 13 | 30 | 2 | CID005280371 | |
| Drug | AC1L1JL9 | 1.30e-04 | 13 | 30 | 2 | CID000005091 | |
| Drug | AC1L18GM | 1.30e-04 | 13 | 30 | 2 | CID000000092 | |
| Drug | 3-hydroxylidocaine | 1.51e-04 | 14 | 30 | 2 | CID000161824 | |
| Drug | sesamol | 1.51e-04 | 14 | 30 | 2 | CID000068289 | |
| Drug | thiethylperazine | 1.74e-04 | 15 | 30 | 2 | CID000005440 | |
| Drug | 4-hydroxymephenytoin | 1.74e-04 | 15 | 30 | 2 | CID000119507 | |
| Drug | N-desethyloxybutynin | 1.74e-04 | 15 | 30 | 2 | CID000133577 | |
| Drug | isopimpinellin | 1.74e-04 | 15 | 30 | 2 | CID000068079 | |
| Drug | aflatoxin Q1 | 1.74e-04 | 15 | 30 | 2 | CID000104757 | |
| Drug | AC1L524X | 1.74e-04 | 15 | 30 | 2 | CID000168572 | |
| Drug | pentafluorobenzoyl chloride | 1.99e-04 | 16 | 30 | 2 | CID000075256 | |
| Drug | cibenzoline | 1.99e-04 | 16 | 30 | 2 | CID000002747 | |
| Drug | alpha-hydroxymetoprolol | 1.99e-04 | 16 | 30 | 2 | CID000114962 | |
| Drug | 2ccu | 1.99e-04 | 16 | 30 | 2 | CID006102789 | |
| Drug | hydroxynefazodone | 2.25e-04 | 17 | 30 | 2 | CID000127096 | |
| Drug | noralfentanil | 2.25e-04 | 17 | 30 | 2 | CID000162172 | |
| Drug | bunitrolol | 2.25e-04 | 17 | 30 | 2 | CID000002473 | |
| Drug | N-desisopropylpropranolol | 2.25e-04 | 17 | 30 | 2 | CID000159899 | |
| Drug | 10-undecynoic acid | 2.25e-04 | 17 | 30 | 2 | CID000031039 | |
| Drug | chlorpromazine sulfoxide | 2.53e-04 | 18 | 30 | 2 | CID000070413 | |
| Drug | NSC404353 | 2.53e-04 | 18 | 30 | 2 | CID000273032 | |
| Disease | solanidine measurement | 4.83e-06 | 4 | 27 | 2 | EFO_0800966 | |
| Disease | unipolar depression, response to selective serotonin reuptake inhibitor | 2.20e-04 | 24 | 27 | 2 | EFO_0003761, EFO_0005658 | |
| Disease | osteoarthritis, hip | 3.21e-03 | 92 | 27 | 2 | EFO_1000786 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LVTMPAALGLWSLYL | 606 | Q9P2K9 | |
| LPLELWRMILAYLHL | 6 | Q9UK96 | |
| PHWGYILLLLLTSVM | 506 | O43246 | |
| LPLSLGLALHLLWTY | 956 | O95980 | |
| LVKTLYMLGSLLHWP | 266 | P35414 | |
| GIWLAYIILVGLLHM | 21 | Q53FV1 | |
| LTHIYLLLGMSLPIW | 406 | Q9UPQ8 | |
| GWLYGLLMLQELHLS | 281 | Q6UXM1 | |
| LGLIWTLILHYSISM | 131 | Q14315 | |
| MTLLPGLLFLTWLHT | 1 | Q9P0M4 | |
| LFPWALMLLSYRGIL | 191 | P46093 | |
| MIWYILIIGILLPQS | 1 | P13674 | |
| HLVLLMWSLIVSLYP | 61 | Q9BYW1 | |
| STTLAWGLLLMILHP | 311 | P10635 | |
| MPLLTLYLLLFWLSG | 1 | Q8TDQ1 | |
| NGRQIMLTYLLPWLH | 1351 | Q5TBA9 | |
| MLTYLLPWLHNIELV | 1356 | Q5TBA9 | |
| PEWLDVYMHILQLLT | 261 | Q96ER3 | |
| MHLLGPWLLLLVLEY | 1 | P20273 | |
| HVLLATWYLLMPPAL | 291 | Q8NGH7 | |
| LTLWSLRGLSLPMYV | 91 | Q5M8T2 | |
| SLLIMLGTLWLGYTL | 561 | Q8NBS3 | |
| LTPWRVYHLISVMIL | 111 | Q9H6L5 | |
| MAWKTLPIYLLLLLS | 1 | Q92954 | |
| LWGLLLPGMQTIYLS | 81 | Q8NGU2 | |
| NLSMLLLLTWPYILL | 246 | Q5BKT4 | |
| EWLTLGLNMPLLAYH | 71 | O95406 | |
| STTLAWGLLLMILHL | 311 | A0A087X1C5 | |
| SYMALFPHLLQPVLW | 681 | P55060 | |
| HWPGASLMLLAVLLL | 66 | Q12767 | |
| MEPHVLGAVLYWLLL | 1 | Q92508 |